Treace Medical Concepts, Inc.
Health
Performance
9.4
Risk
Sell
Buy
Curious about the Scores? Learn more.

Treace Medical Concepts, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

03.03.2026
Red alert. Risk levels out of control.
10.11.2025
Rock bottom. The fall’s complete, stability nowhere to be found.
10.11.2025
Momentum tanked. Clearly underperforming.
TMCI
Treace Medical Concepts, Inc.
4.08
-3.66%
9.4
Sell
Buy
Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Treace Medical Concepts, Inc. do? Business model and key facts

Get the full picture of Treace Medical Concepts, Inc.: what it builds, where it operates, and how it makes money.

Treace Medical Concepts, Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 450

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

shop
Company facts
John T. Treace
CEO
450
Employees worldwide
shop
Performance
-26.05%
Last 12 months
-85.02%
Last 5 years
shop
Growth
$212.69M
Revenue year
$-59,002,000
Net income
shop
Valuation
$278.95M
Market Cap
-2.63
Price/Earnings Ratio

Stocks related to Treace Medical Concepts, Inc.

Selected based on industry alignment and relative market positioning.

VREX
Varex Imaging Corporation
10.69
-0.33%
7.2
Sell
Buy
Varex Imaging Corporation
PACB
Pacific Biosciences of California, Inc.
1.40
-0.36%
8.6
Sell
Buy
Pacific Biosciences of California, Inc.
OFIX
Orthofix Medical Inc.
11.12
-4.43%
7.2
Sell
Buy
Orthofix Medical Inc.
RXST
RxSight, Inc.
5.40
+2.85%
8.7
Sell
Buy
RxSight, Inc.
ANIK
Anika Therapeutics, Inc.
15.30
+0.92%
4.8
Sell
Buy
Anika Therapeutics, Inc.

Events and news impacting Treace Medical Concepts, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Treace Medical Concepts, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.